| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jeremy Mennis, Thomas P McKeon, Gerald J Stahle. Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults. Addictive behaviors. vol 138. 2022-11-22. PMID:36413909. |
understanding how recreational cannabis legalization may impact cannabis use disorder (cud) among adolescents and young adults is key to developing an appropriate public health response. |
2022-11-22 |
2023-08-14 |
Not clear |
| Jeremy Mennis, Thomas P McKeon, Gerald J Stahle. Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults. Addictive behaviors. vol 138. 2022-11-22. PMID:36413909. |
this research investigates whether associations among adolescent and young adult perception of risk of harm from cannabis use, prevalence of past-month cannabis use, and rate of cud treatment admissions changed following recreational cannabis legalization in the us, 2008-2019. |
2022-11-22 |
2023-08-14 |
Not clear |
| Zachary W Adams, Brigid R Marriott, Leslie A Hulvershorn, Jesse Hinckle. Treatment of Adolescent Cannabis Use Disorders. Child and adolescent psychiatric clinics of North America. vol 32. issue 1. 2022-11-21. PMID:36410901. |
this review summarizes treatments for cannabis use disorder (cud) in adolescents. |
2022-11-21 |
2023-08-14 |
Not clear |
| Zachary W Adams, Brigid R Marriott, Leslie A Hulvershorn, Jesse Hinckle. Treatment of Adolescent Cannabis Use Disorders. Child and adolescent psychiatric clinics of North America. vol 32. issue 1. 2022-11-21. PMID:36410901. |
the best supported cud treatments are cognitive behavioral psychotherapies, including family-based models that facilitate environmental changes and youth-focused models that incorporate skills training, motivational interviewing, and contingency management to promote reductions in cannabis use. |
2022-11-21 |
2023-08-14 |
Not clear |
| Zachary W Adams, Brigid R Marriott, Leslie A Hulvershorn, Jesse Hinckle. Treatment of Adolescent Cannabis Use Disorders. Child and adolescent psychiatric clinics of North America. vol 32. issue 1. 2022-11-21. PMID:36410901. |
further research is needed on the efficacy and implementation of existing treatments given the changes in cannabis use trends over time and on emerging technologies that may expand access to evidence-based cud treatments. |
2022-11-21 |
2023-08-14 |
Not clear |
| Gao Jiayang, Guo Xin, Yan Chunxia, Gong Xiaojuan, Ma Pan, Gu Shanzhi, Zhang Ba. Transcriptome-wide association study by different approaches reveals candidate causal genes for cannabis use disorder. Gene. 2022-11-15. PMID:36379386. |
cannabis is one of the most commonly used psychoactive substances, which could induce moderate-severe cannabis use disorders (cud). |
2022-11-15 |
2023-08-14 |
Not clear |
| Christina A Brezing, Frances R Levi. Applications of technology in the assessment and treatment of cannabis use disorder. Frontiers in psychiatry. vol 13. 2022-11-07. PMID:36339845. |
cannabis use and cannabis use disorder (cud) have been increasing. |
2022-11-07 |
2023-08-14 |
Not clear |
| Patric Bialas, Claudia Böttge-Wolpers, Mary-Ann Fitzcharles, Sven Gottschling, Dieter Konietzke, Stephanie Juckenhöfel, Albrecht Madlinger, Patrick Welsch, Winfried Häuse. Cannabis use disorder in chronic pain patients: over- and underestimation in a cross-sectional observational study in three German pain management centres. Pain. 2022-11-03. PMID:36327134. |
there are concerns that cannabis use disorder (cud) may develop in chronic pain patients prescribed medical cannabis (mc). |
2022-11-03 |
2023-08-14 |
human |
| Patric Bialas, Claudia Böttge-Wolpers, Mary-Ann Fitzcharles, Sven Gottschling, Dieter Konietzke, Stephanie Juckenhöfel, Albrecht Madlinger, Patrick Welsch, Winfried Häuse. Cannabis use disorder in chronic pain patients: over- and underestimation in a cross-sectional observational study in three German pain management centres. Pain. 2022-11-03. PMID:36327134. |
the criteria for cud according to the statistical manual for mental disorders version 5 (dsm-5) were not developed for identification of patients using cannabis for therapeutic reasons. |
2022-11-03 |
2023-08-14 |
human |
| Namkee G Choi, C Nathan Marti, Diana M DiNitto, Bryan Y Cho. Psychological Distress, Cannabis Use Frequency, and Cannabis Use Disorder Among US Adults in 2020. Journal of psychoactive drugs. 2022-11-01. PMID:36318094. |
using 2020 national survey on drug use and health data (n = 27,170, age 18+), we examined associations of psychological distress with: (1) cannabis use frequency among all adults, and (2) cannabis use disorder (cud) among cannabis users. |
2022-11-01 |
2023-08-14 |
Not clear |
| Theresa E Matson, Gwen T Lapham, Jennifer F Bobb, Malia Oliver, Kevin A Hallgren, Emily C Williams, Katharine A Bradle. Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care. JAMA network open. vol 5. issue 11. 2022-11-01. PMID:36318205. |
cannabis use is prevalent and increasing, and frequent use intensifies the risk of cannabis use disorder (cud). |
2022-11-01 |
2023-08-14 |
Not clear |
| Theresa E Matson, Gwen T Lapham, Jennifer F Bobb, Malia Oliver, Kevin A Hallgren, Emily C Williams, Katharine A Bradle. Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care. JAMA network open. vol 5. issue 11. 2022-11-01. PMID:36318205. |
cud is underrecognized in medical settings, but a validated single-item cannabis screen could increase recognition. |
2022-11-01 |
2023-08-14 |
Not clear |
| Llewellyn Mills, Adrian Dunlop, Mark Montebello, Jan Copeland, Raimondo Bruno, Meryem Jefferies, Iain Mcgregor, Nicholas Lintzeri. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Substance abuse treatment, prevention, and policy. vol 17. issue 1. 2022-10-08. PMID:36209081. |
this paper is a secondary analysis of a randomised placebo-controlled trial of nabiximols for the treatment of cannabis use disorder (cud), aiming to identify which client and treatment characteristics impact treatment engagement and outcomes. |
2022-10-08 |
2023-08-14 |
Not clear |
| Ryan Petros, Denise D Walker, Adam Davis, Maria Monroe-DeVit. Young adults with psychosis: Intentions for cannabis reduction and cessation based on theory of planned behavior. Psychiatric rehabilitation journal. 2022-10-06. PMID:36201809. |
young adults experiencing a first episode of psychosis (fep) have high rates of cannabis use and cannabis use disorder (cud). |
2022-10-06 |
2023-08-14 |
Not clear |
| Michael F Orr, Luke F Heggeness, Nirvi Mehta, Jacob Moya, Kara Manning, Lorra Garey, Julianna Hogan, Marcel de Dios, Michael J Zvolensk. Anxiety sensitivity and cigarette use on cannabis use problems, perceived barriers for cannabis cessation, and self-efficacy for quitting among adults with cannabis use disorder. Addictive behaviors. vol 137. 2022-10-04. PMID:36194977. |
many individuals diagnosed with cannabis use disorder (cud) report a desire to quit using cannabis due to problems associated with use. |
2022-10-04 |
2023-08-14 |
Not clear |
| Michael F Orr, Luke F Heggeness, Nirvi Mehta, Jacob Moya, Kara Manning, Lorra Garey, Julianna Hogan, Marcel de Dios, Michael J Zvolensk. Anxiety sensitivity and cigarette use on cannabis use problems, perceived barriers for cannabis cessation, and self-efficacy for quitting among adults with cannabis use disorder. Addictive behaviors. vol 137. 2022-10-04. PMID:36194977. |
the sample consisted of 132 adult cannabis users who met criteria for cud and were interested in quitting (38 % female; 63.6 % black; m |
2022-10-04 |
2023-08-14 |
Not clear |
| Emese Kroon, Lauren Kuhns, Annette Dunkerbeck, Janna Cousij. The who and how of attentional bias in cannabis users: associations with use severity, craving, and interference control. Addiction (Abingdon, England). 2022-10-03. PMID:36189776. |
cognitive and motivational processes are thought to underlie cannabis use disorder (cud), but research assessing how cognitive processes (e.g. |
2022-10-03 |
2023-08-14 |
Not clear |
| David S Fink, Dvora Shmulewitz, Zachary L Mannes, Malka Stohl, Ofir Livne, Melanie Wall, Deborah S Hasi. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use. Journal of psychiatric research. vol 155. 2022-10-01. PMID:36182768. |
the dsm-5 definition of cannabis use disorder (cud) differs from dsm-iv by combining abuse and dependence criteria (without the legal criterion) and including withdrawal and craving criteria. |
2022-10-01 |
2023-08-14 |
human |
| David S Fink, Dvora Shmulewitz, Zachary L Mannes, Malka Stohl, Ofir Livne, Melanie Wall, Deborah S Hasi. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use. Journal of psychiatric research. vol 155. 2022-10-01. PMID:36182768. |
regression models estimated the associations between binary dsm-5 cud and severity levels with a set of validators, including cannabis use variables, psychopathology, and functional impairment. |
2022-10-01 |
2023-08-14 |
human |
| David S Fink, Dvora Shmulewitz, Zachary L Mannes, Malka Stohl, Ofir Livne, Melanie Wall, Deborah S Hasi. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use. Journal of psychiatric research. vol 155. 2022-10-01. PMID:36182768. |
dsm-5 cud and all severity levels were associated with cannabis use validators, including number of days used, self-reporting that cannabis use was a major problem, and greater cannabis craving. |
2022-10-01 |
2023-08-14 |
human |